ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

No reading has been made of this study yet; what is shown is how our rules link it today.

4 links0 made here, not in the record2 judgments1 judge (our rules as one)0 record changes seen
Our rules
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT03439709Multicenter Evaluation ofthe Effect of UpfrontRadiosurgery on ResidualGrowth Hormone-secretingPituitary AdenomaSamsung Medical CenterPhase 3 · unknownRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSGrowth Hormone-Secreting Pi…The registry's MeSH filing›No judgment recorded. Shown as the registry files it.AcromegalyThe registry's MeSH filing›As of now · Our main-condition rule (R9) · Main conditionMain conditionPituitary NeoplasmsThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.DRUGSLanreotideEntry “Lanreotide 60Mg Solution for I…›As of now · Our role rule · BackgroundBackground

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Growth Hormone-Secreting Pituitary Adenoma

From the registry record0 judgments on this link
RegistryGrowth Hormone-Secreting Pituitary Adenoma, as filedthe registry files the study under it
=as filed
No judgmentUnchangedshown as the registry files it

All judgments on this study

WhenLinkJudgeDecisionState
As of nowAcromegalyOur main-condition rule (R9)Main conditionCurrent
As of nowLanreotideOur role ruleBackgroundCurrent